Literature DB >> 19350121

Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis.

Eduardo Ramacciotti1, Angela E Hawley, Diana M Farris, Nicole E Ballard, Shirley K Wrobleski, Daniel D Myers, Peter K Henke, Thomas W Wakefield.   

Abstract

Microparticles (MP) are lipid vesicles from platelets, leukocytes and endothelial cells that are involved in early thrombogenesis. We evaluated a detailed time-course analysis of MPs on thrombogenesis and the associated tissue factor (TF) activity in wild-type, in gene-deleted for E- and P-selectins and with high levels of P-selectin expression after the initiation of venous thrombosis in mice. Inferior vena cava (IVC) ligation was performed on C57BL/6 mice (n = 191, 59 = wild-type [WT], 55 = gene-deleted for E- and P - selectins [knock-outs, EPKO] and 77 = elevated levels of soluble P-selectin, named Delta Cytoplasmic Tail (DeltaCT). Animals were euthanised at various time points to assess MP production, origin and thrombus weight. MPs were re-injected into separate mice at concentrations of 80,000 and 160,000 units, as well as from different ages. In addition, MPs from thrombosed animals were pooled and TF activity quantitated using a chromogenic assay. Thrombus weight correlated negatively with MPs derived from leukocytes, and positively with MPs derived from platelets for WT animals (p < 0.05), while MPs from platelets presented a positive correlation to thrombus weight in the WT and EPKO groups (p < 0.01). Total MPs correlated negatively with thrombus weight in the DeltaCT group (p < 0.05). MP re-injections led to greater thrombus weight, while older MP reinjections tended to form larger thrombus than younger. Finally, TF bearing MPs showed a significant correlation to MP concentrations (R = 0.99). In conclusion, MPs appear to be an important element in venous thrombogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19350121      PMCID: PMC2772897     

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  27 in total

Review 1.  Inflammation and thrombosis.

Authors:  C T Esmon
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

2.  Endothelial cell activation by leukocyte microparticles.

Authors:  M Mesri; D C Altieri
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

3.  Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.

Authors:  Thomas J Podor; Davindra Singh; Paul Chindemi; Denise M Foulon; Robert McKelvie; Jeffrey I Weitz; Richard Austin; Ghislain Boudreau; Richard Davies
Journal:  J Biol Chem       Date:  2001-12-14       Impact factor: 5.157

Review 4.  The role of platelets in decrypting monocyte tissue factor.

Authors:  B Osterud
Journal:  Semin Hematol       Date:  2001-10       Impact factor: 3.851

5.  Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity.

Authors:  Florence Sabatier; Veronique Roux; Francine Anfosso; Laurence Camoin; José Sampol; Françoise Dignat-George
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

Review 6.  Circulating tissue factor and thrombosis.

Authors:  U Rauch; Y Nemerson
Journal:  Curr Opin Hematol       Date:  2000-09       Impact factor: 3.284

7.  Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A.

Authors:  Ingrid Hrachovinová; Beatrice Cambien; Ali Hafezi-Moghadam; János Kappelmayer; Raymond T Camphausen; Angela Widom; Lijun Xia; Haig H Kazazian; Robert G Schaub; Rodger P McEver; Denisa D Wagner
Journal:  Nat Med       Date:  2003-07-13       Impact factor: 53.440

8.  Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner.

Authors:  E Biró; K N Sturk-Maquelin; G M T Vogel; D G Meuleman; M J Smit; C E Hack; A Sturk; R Nieuwland
Journal:  J Thromb Haemost       Date:  2003-12       Impact factor: 5.824

9.  P-selectin and leukocyte microparticles are associated with venous thrombogenesis.

Authors:  Daniel D Myers; Angela E Hawley; Diana M Farris; Shirley K Wrobleski; Porama Thanaporn; Robert G Schaub; Denisa D Wagner; Anjali Kumar; Thomas W Wakefield
Journal:  J Vasc Surg       Date:  2003-11       Impact factor: 4.268

10.  Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.

Authors:  Shahrokh Falati; Qingde Liu; Peter Gross; Glenn Merrill-Skoloff; Janet Chou; Erik Vandendries; Alessandro Celi; Kevin Croce; Barbara C Furie; Bruce Furie
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  28 in total

1.  Abnormal P-selectin localization during megakaryocyte development determines thrombosis in the gata1low model of myelofibrosis.

Authors:  Eva Zetterberg; Maria Verrucci; Fabrizio Martelli; Maria Zingariello; Laura Sancillo; Emanuela D'Amore; Rosa Alba Rana; Anna Rita Migliaccio
Journal:  Platelets       Date:  2013-10-31       Impact factor: 3.862

2.  Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability.

Authors:  M M Aleman; C Gardiner; P Harrison; A S Wolberg
Journal:  J Thromb Haemost       Date:  2011-11       Impact factor: 5.824

Review 3.  Microparticle analysis in disorders of hemostasis and thrombosis.

Authors:  Micah J Mooberry; Nigel S Key
Journal:  Cytometry A       Date:  2015-02-20       Impact factor: 4.355

4.  Diagnostic value of platelet-derived microparticles in pulmonary thromboembolism: A population-based study.

Authors:  Minglian Wang; Yingyun Fu; Lan Xu; Lu Xiao; Yongjian Yue; Shengguo Liu; Qijun Huang; Shulin Li; Yazhen Li
Journal:  Exp Ther Med       Date:  2018-08-07       Impact factor: 2.447

Review 5.  Microparticles in hemostasis and thrombosis.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Circ Res       Date:  2011-05-13       Impact factor: 17.367

Review 6.  Emerging paradigms in arterial thrombosis.

Authors:  James W Wisler; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

Review 7.  Do galectins play a role in venous thrombosis? a review.

Authors:  Jose A Diaz; Eduardo Ramacciotti; Thomas W Wakefield
Journal:  Thromb Res       Date:  2009-12-02       Impact factor: 3.944

8.  Functional characterization of tissue factor in von Willebrand factor-dependent thrombus formation under whole blood flow conditions.

Authors:  Yasunori Matsunari; Mitsuhiko Sugimoto; Masaaki Doi; Hideto Matsui; Masahiko Kawaguchi
Journal:  Int J Hematol       Date:  2016-08-25       Impact factor: 2.490

9.  P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis.

Authors:  Eduardo Ramacciotti; Daniel D Myers; Shirley K Wrobleski; K Barry Deatrick; Frank J Londy; John E Rectenwald; Peter K Henke; Robert G Schaub; Thomas W Wakefield
Journal:  Thromb Res       Date:  2009-12-04       Impact factor: 3.944

10.  Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction.

Authors:  Birgit A Steppich; Siegmund Lorenz Braun; Andreas Stein; Gabriele Demetz; Philip Groha; Albert Schömig; Nicolas von Beckerath; Adnan Kastrati; Ilka Ott
Journal:  Thromb J       Date:  2009-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.